Molsidolat (Molsidomine)

Molsidomine, the active ingredient in Molsidolat, is a nitric oxide donor presented as an oral tablet for oral administration. It belongs to the vasodilator class and is used to relieve chest pain caused by reduced blood flow to the heart. The medication is indicated for patients with angina pectoris and chronic stable angina.

GNH USA supplies Molsidolat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across markets with reliable logistics and documentation support.

Molsidomine is a nitric oxide donor used in the management of coronary artery disease. - Angina pectoris: reduces the frequency and severity of chest pain episodes. - Chronic stable angina: improves exercise tolerance and reduces ischemic episodes. - Ischemic heart disease: decreases myocardial oxygen demand by vasodilation.

Molsidomine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Headache: mild to moderate intensity, often transient. - Dizziness: may occur with postural changes. - Flushing: warm sensation, usually short‑lived. - Hypotension: mild blood pressure reduction. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure requiring medical attention. - Syncope: fainting episodes due to sudden hypotension. - Allergic reactions: rash, pruritus, or angioedema. - Myocardial infarction: rare but reported in vulnerable patients. - Severe bradycardia: markedly slow heart rate. - Hepatic dysfunction: abnormal liver enzymes in rare cases.

Before prescribing molsidomine, clinicians should consider several safety aspects. - Monitor blood pressure: watch for symptomatic hypotension. - Use cautiously in severe hepatic impairment: dose adjustment may be required. - Avoid concomitant use with other nitrates: risk of additive vasodilation. - Caution in elderly patients: increased sensitivity to vasodilatory effects. - Pregnancy and breastfeeding: safety not established; use only if benefit outweighs risk. - Store at room temperature: keep in the original pack, protect from moisture.

Molsidomine can interact with several drug classes, necessitating careful review of patient medication lists.

Major Interactions (Avoid): - Nitrates: additive hypotensive effect may lead to severe blood pressure drop. - Phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Sodium nitroprusside: combined vasodilatory action can cause dangerous hypotension.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance overall blood pressure‑lowering effect. - Beta‑blockers: can mask tachycardia signs of hypotension. - Calcium channel blockers: additive vasodilation may require dose adjustments.